Cite
MLA Citation
Michael S. Hofman et al.. “TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603).” BJU international, vol. 124, n.d., pp. 5–13. http://access.bl.uk/ark:/81055/vdc_100095338534.0x00001a